MiR ‐34 by targeting p53 induces apoptosis and DNA damage in paclitaxel‐resistant human oral squamous carcinoma cells
Chemical Biology & Drug Design · 2023
DOI: 10.1111/cbdd.14240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2023. Verfasst von Bardia Mortezagholi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: MicroRNAs, Carcinoma, Squamous Cell, Mouth Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
MicroRNA‐34 (miR‐34) is one the most important tumor suppressor miRNAs involving in the various aspects of oral cancer. The present study aimed to evaluate the effects of miR‐34 restoration in OECM‐1 oral cancer resistant to paclitaxel (OECM‐1/PTX) and its underlying mechanisms through p53‐mediated DNA damage and apoptosis. OECM‐1 and OECM‐1/PTX were transfected with miR‐34 mimic and inhibitor. Cellular proliferation and apoptosis were evaluated through MTT assay and flow cytometry, respectively. The mRNA and protein expression levels of p53, p‐glycoprotein (P‐gp), ATM, ATR, CHK1, and CHK2 were assessed through qRT‐PCR and western blotting. Rhodamin123 uptake assay was used to measure the P‐gp activities. P53 expression was also suppressed by sing a siRNA transfection of cells. The expression levels of miR‐34 were downregulated in OECM‐1/PTX. Restoration of miR‐34 led to increase in cytotoxic effects of paclitaxel in cells. In addition, the expression levels and activities of P‐gp were reduced following miR‐34 transfection. miR‐34 transfection upregulated the p53, ATM, ATR, CHK1, and CHK2 expression levels in OECM‐1/PTX cells. Furthermore, cells transfected with miR‐34 showed higher levels of apoptosis. miR‐34 restoration reverses paclitaxel resistance in OECM‐1 oral cancer. The chemosensitive effects of miR‐34 is mediated through increasing DNA damage and apoptosis in a p53 depended manner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.
- Dental Research Center, Faculty of Dentistry, Islamic Azad University of Medical Sciences, Tehran, Iran.
- Faculty of Dentistry, Islamic Azad University of Medical Sciences, Tehran, Iran.
- Dental Materials Research Center, Dental School, Islamic Azad University of Medical Sciences, Tehran, Iran.
- School of Dentistry, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
- Faculty of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
Zitieren
APA
Mortezagholi, B., Nasiri, K., Movahed, E., Dadgar, E., Nejati, S. T., Hassani, P., Esfahaniani, M., & Rafieyan, S. (2023). MiR ‐34 by targeting p53 induces apoptosis and DNA damage in paclitaxel‐resistant human oral squamous carcinoma cells. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14240
Vancouver
Mortezagholi B, Nasiri K, Movahed E, Dadgar E, Nejati ST, Hassani P, et al. MiR ‐34 by targeting p53 induces apoptosis and DNA damage in paclitaxel‐resistant human oral squamous carcinoma cells. Chemical Biology & Drug Design. 2023. doi:10.1111/cbdd.14240
BibTeX
@article{Mortezagholi2023,
author = {Mortezagholi, Bardia and Nasiri, Kamyar and Movahed, Emad and Dadgar, Esmaeel and Nejati, Seyedeh Tabasom and Hassani, Pardis and Esfahaniani, Mahla and Rafieyan, Sona},
title = {MiR ‐34 by targeting p53 induces apoptosis and DNA damage in paclitaxel‐resistant human oral squamous carcinoma cells},
journal = {Chemical Biology & Drug Design},
year = {2023},
doi = {10.1111/cbdd.14240}
}
EUVIMED